[1] World Health Organization.Cardiovascular diseases (CVDs)[EB/OL].(2017-05-17)[2021-9-10]
[2] Conte SM, Vale PR.Peripheral rrterial disease[J].Heart Lung Circ,2018,27(4):427-432.
[3] Riviere AB,Bouee S,Laurendeau C,et al.Outcomes and management costs of peripheral arterial disease in France[J].Journal of Vascular Surgery,2018 ,67(6):1834-1843.
[4] 徐静,孟欣欣,赵娣,等.慢病管理对颈动脉粥样硬化的影响及相关指标分析[J].中华健康管理学杂志,2019,13(5):446-451.
[5] 国务院办公厅.中国防治慢性病中长期规划(2017—2025 年)[EB/OL].[2019-12-01].
[6] Dihlmann S,Peters A,Hakimi M .Development of arteriosclerosis[J].GEFASSCHIRURGIE,2019,24(2):195-205.
[7] Charasson M,Mahe G,Le Brun C,et al.Atherosclerosis knowledge - diagnosis and management in primary care[J].Vasa-European Journal of Vascular Medicine,2018,47(6):465-470.
[8] 孙小霞. 健康管理对体检人群不良生活方式的纠正作用分析[J].中国社区医师,2019,35(20):168-170.
[9] 立清,管梦琪,舒召慧.大数据在健康管理中的应用研究[J].广西社会科学,2021(8):80-85.
[10] Allegrante JP, Wells M, Peterson JC.Interventions to Support Behavioral Self-Management of Chronic Diseases[J].Annual Review of Public Health,2019,40: 127-146.
[11] Mamudu HM,Alamian A,Paul T,et al.Diabetes, subclinical atherosclerosis and multiple cardiovascular risk factors in hard-to-reach asymptomatic patients[J]. Diab Vasc Dis Res, 2018 ,15(6):519-527.
[12] Damar IH, Eroz R.The Role of Macrophages in Atherosclerosis: An Overview[J]. Erciyes Medica Journal,2021,43(1):9-12.
[13] Abola MTB, Golledge J, Miyata T, et al.Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee[J].Journal of Atherosclerosis and Thrombosis,2020,27(8):809-907.
[14] Aziz MU,Singh S.Computed tomography of coronary artery atherosclerosis: A review[J].Journal of Medical Imaging abd Radiation Sciences,2021,52(3):S19-S39.
[15] Fernstrom M, Fernberg U, Hurtig-Wennlof A .The importance of cardiorespiratory fitness and sleep duration in early CVD prevention: BMI, resting heart rate and questions about sleep patterns are suggested in risk assessment of young adults, 18-25 years: The cross-sectional lifestyle, biomarkers and atherosclerosis (LBA) study[J].BMC Public Health,2020,20(1).
[16] Farrington Liz,Mortimore Gerri.Chronic limb ischaemia: case study and clinical literature review[J].British journal of nursing,2021,30(14): 846-851.
[17] 朱俊亮,梁联超,杨寅,等. 健康管理对动脉硬化人群干预效果评价[J]. 社区医学杂志,2021,19(24):1456-1460.
[18] 靳春梅,牛永红,王清清. 健康管理预防颈动脉硬化效果分析[J]. 健康前沿,2019,28(4):9.
[19] Wen F,Liu Y,Wang, HY.Clinical Evaluation Tool for Vascular Health-Endothelial Function and Cardiovascular Disease Management[J].CELLS,2022,11(21).
[20] Yang Jie,Yin Fu, Zang Jun, et al.Carotid atherosclerosis and contributing factors in a population at high risk of stroke[J].Chinese Journal of Health Management,2019,13(2): 102-107.
[21] Xing LY,Li R,Zhang SL,et al.High Burden of Carotid Atherosclerosis in Rural Northeast China: A Population-Based Study[J].Frontiers in Neurology,2021,12.
[22] Pan Wen,Zhang Limin,Li Ru,et al.Prevalence and risk factors of carotid atherosclerosis among rural resident aged 40 years and older in Liaoning Province[J].China Journal of Public Health,2021,37(1):92-96.
[23] 谢伟玲,秦国伟,杨敏,等.中年动脉硬化患者危险因素及综合护理干预效果分析[J].国际护理学杂志,2018,37(18):2468-2472.
[24] 中国心血管病风险评估和管理指南编写联合委员.中国心血管病风险评估和管理指南[J].中国循环杂志,2019,34(1):4-28.
[25] 朱文华,祝悦,陈丽英,等. 动脉硬化早期风险评估与健康管理[J].当代医学,2020,26(30):1-4.
[26] Pella Zuzana,Pella Dominik,Paralic Jan,et al.Analysis of risk factors in patients with subclinical atherosclerosis and increased cardiovascular risk using factor analysis[J].Diagnostics(Basel,Switzerland),2021,11(7).
[27] 张静波,刘雅茜,杨建国,等.北京市青年、中年和老年健康体检人群中异常指标检出的分布特征[J].中国临床医生杂志,2018,46(4):414-416.
[28] 于昊,贾晓东,张楠,等.青年女性亚临床动脉粥样硬化危险因素研究[J]. 大连医科大学学报,2021,43(5):419-423,429.
[29] Rumenapf G,Morbach S,Schmidt A,et al.Intermittent claudication and asymptomatic peripheral arterial disease[J].Dtsch Arztebl Int,2020,117(11):188-193.
[30] Gur DO.Exercise and Peripheral Arteriosclerosis[J]. Physical Exercise For Human Health,2020,1228:181-193 .
[31] Xu Jing,Meng Xinxin,Zhao Di,et al.Effects of chronic disease management on patients with carotid?atherosclerosis and the analysis of the related indicators[J].Chinese Journal of Health Management,2019,13(5):446-451.
[32] Fernberg U, Fernstrom M, Hurtig-Wennlof A.Higher Total Physical Activity is Associated with Lower Arterial Stiffness in Swedish, Young Adults: The Cross-Sectional Lifestyle, Biomarkers, and Atherosclerosis Study[J].Vascular Health abd Risk Management,2021,17:175-185.
[33] 李晓静,洪海鸥,郑浩然,等.健康体检人群中血脂与亚临床动脉硬化检测指标之间的关系[J].中华全科医学,2019,17(7):1090-1092,1244.
[34] 巩红,韩拓,王倩,等. 正常体质量肥胖与颈动脉硬化及外周动脉硬化的相关性研究[J]. 西安交通大学学报(医学版),2022,43(3):343-347.
[35] Ojima S, Kubozono T, Kawasoe S,et al.Gender differences in the risk factors associated with atherosclerosis by carotid intima-media thickness, plaque score, and pulse wave velocity[J].Heart and Vessels,2021,36(7): 934-944.
[36] 左云,朱春景,李亚昆,等.延伸护理在2型糖尿病合并颈动脉粥样硬化患者中的应用效果[J]. 河北医药,2020,42(20):3194-3197.
[37] 赵鹏栋,肖汉光,任慧娇,等.基于脉搏波传导速度的动脉硬化无创检测方法进展[J].中国动脉硬化杂志,2021,29(1):82-86.
[38] 曾兰芬,赵萍,万蓉,等. 彩色多普勒超声在2型糖尿病合并亚临床甲减患者下肢动脉硬化诊断价值[J].中国超声医学杂志,2019,35(1):59-62.
[39] Soni M, Ambrosino M, Jacoby DS.The Use of Subclinical Atherosclerosis Imaging to Guide Preventive Cardiology Management[J].Curr Cardiol Rep, 2021, 23(6):61.
[40] Mortensen MB, Blaha MJ.Is There a Role of Coronary CTA in Primary Prevention Current State and Future Directions[J].Curent Atherosclerosis Reports,2021,23(8).
[41] Chen Shengnan,Li Ning,Shen Yan.Value of 2 risk prediction models in predicting the risk of atherosclerosis in patients with chronic kidney disease[J].Journal of Central South University, Medical sciences,2021,46(9):966-973. |
